business
With 10,000 lawsuits pending, Medtronic’s hernia mesh faces its first jury
Summary by The Minneapolis Editorial Desk · Based on reporting from Star Tribune
· July 24, 2026
· 1 min read
The bellwether trial is testing allegations that the Minnesota-run company’s mesh products injured patients and were marketed with misleading safety claims.
Story provenance No corrections
Summary created by The Minneapolis Editorial Desk — automated, rule-governed Original reporting Star Tribune Original story Read at the source Source published Jul 24, 2026 Indexed here Jul 24, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Why this matters in The Minneapolis
The outcome of this trial will have significant implications for Medtronic, a major employer in the Twin Cities area, and could potentially impact the local economy. As a prominent business in the community, Medtronic's reputation and financial well-being are closely tied to the region's. A negative verdict could lead to a substantial financial burden on the company, potentially affecting its operations and workforce in Minneapolis. Furthermore, the trial's focus on marketing practices raises questions about the regulation of medical devices in Minnesota and the measures in place to protect consumers. The state's medical device industry is a significant sector, and this case may prompt closer examination of industry practices and regulatory oversight. The verdict will be closely watched by the local business community, medical professionals, and patients who have been affected by Medtronic's hernia mesh products.
About this story
Original reporting by Star Tribune . The Minneapolis surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Star Tribune . Have a tip or correction? Contact our newsroom .
Category: business ·
Published: July 24, 2026 ·
Source: Star Tribune ·
Reading time: 1 min
Frequently asked about this story
What is this story about? The bellwether trial is testing allegations that the Minnesota-run company’s mesh products injured patients and were marketed with misleading safety claims.
When was this published? This article was first published on July 24, 2026 by Star Tribune and curated for The Minneapolis readers.
Who reported this story? This story was reported by Star Tribune. To learn more about how The Minneapolis selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from The Minneapolis, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter